Rentschler Biopharma announces strategic realignment of its global business operations
January 30, 2025 08:00 ET
|
Rentschler Biopharma SE
LAUPHEIM, Germany, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced today a...
PharmAla Issues Q1 Financial Statements
January 29, 2025 16:10 ET
|
PharmAla Biotech
PharmAla releases its Q1 financial statements
Lifecore Biomedical Announces Special Stockholder Meeting
January 17, 2025 17:24 ET
|
Lifecore Biomedical, Inc.
CHASKA, Minn., Jan. 17, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today...
Yseop Kicks Off 2025 by Strengthening Its Leadership in Generative AI for Life Sciences
January 15, 2025 09:00 ET
|
Yseop
NEW YORK, Jan. 15, 2025 (GLOBE NEWSWIRE) -- Yseop, a global leader in Generative AI for life sciences, is starting 2025 with a series of achievements and strategic collaborations that underscore its...
Global Leader in Specialty Therapeutics Selects Kneat to Digitize Validation
January 09, 2025 17:17 ET
|
kneat.com, inc.
Leading European global therapeutics company more than 20,000 people selects Kneat to digitize its validation processes.
Next-generation RNA company Inverna Therapeutics launched by Argobio and University of Southern Denmark
January 07, 2025 04:00 ET
|
AKAMPION
Novel paradigm for therapeutics based on RNA splicing modulationLead program in Huntington’s disease Denmark – Odense – 07/01/2025 – Inverna Therapeutics, a novel Danish biotech company at the...
ON Partners Strengthens Healthcare and Life Sciences Expertise with Strategic Investment & Expansion
January 06, 2025 09:08 ET
|
ON Partners
CLEVELAND, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ON Partners, a pure-play retained executive search firm that builds diverse C-level and board leadership teams, has expanded its focus in the healthcare...
Quantum BioPharma Diversifies Treasury with the Purchase of USD $1,000,000 of Bitcoin (BTC) and Other Cryptocurrencies and to Allow for Future Financings and Other Transactions in Cryptocurrency
December 20, 2024 07:30 ET
|
Quantum BioPharma
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval...
Alira Health Secures Up to $100M Growth Debt Facility from Symbiotic Capital to Propel Strategic Expansion and Patient-Enabled Innovation
December 17, 2024 09:00 ET
|
Alira Health
Alira Health announced today the securing of up to $100 million in growth debt from Symbiotic Capital, a premier healthcare and life sciences investor.
Sobi Announces FDA Acceptance of New Drug Application for Avatrombopag (DOPTELET®) for the Treatment of Pediatric Immune Thrombocytopenia
December 12, 2024 06:59 ET
|
Sobi, Inc.
WALTHAM, Mass., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi®), today announced that the U.S. Food and Drug Administration...